$NLNK LUMOS PHARMA, INC. Insider Trading Week 30/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LUMOS PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LUMOS PHARMA, INC. in week 30/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | A | 1.77 | 13,424 | 23,760 | 13,424 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | A | 1.77 | 10,739 | 19,008 | 10,739 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | JOHNSON CHAD ALLEN | Director | Option Exercise | D | 7.07 | 48,324 | 341,651 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 4,437 | 7,853 | 4,437 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 17.42 | 13,309 | 231,843 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 2,391 | 4,232 | 2,391 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 10.78 | 4,782 | 51,550 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 8,887 | 15,730 | 8,887 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 10.78 | 17,774 | 191,604 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 1,588 | 2,811 | 1,588 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 44.60 | 6,349 | 283,165 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 5,220 | 9,239 | 5,220 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 21.23 | 15,659 | 332,441 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 4,000 | 7,080 | 4,000 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 14.71 | 12,000 | 176,520 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 3,968 | 7,023 | 3,968 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 13.30 | 11,902 | 158,297 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 1,190 | 2,106 | 1,190 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 10.02 | 2,380 | 23,848 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 5,952 | 10,535 | 5,952 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 10.02 | 11,904 | 119,278 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 11,905 | 21,072 | 11,905 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 3.07 | 23,809 | 73,094 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | A | 1.77 | 11,905 | 21,072 | 11,905 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Talarico Ernest III | Director | Option Exercise | D | 3.07 | 23,809 | 73,094 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 2,445 | 4,328 | 2,445 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,582 | 8,110 | 4,582 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,582 | 8,110 | 4,582 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,587 | 8,119 | 4,587 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 6,875 | 12,169 | 6,875 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 6,875 | 12,169 | 6,875 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 15,889 | 28,124 | 15,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 9,167 | 16,226 | 9,167 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 7.85 | 110,000 | 863,500 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,297 | 7,606 | 4,297 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 6,641 | 11,755 | 6,641 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 7,813 | 13,829 | 7,813 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 8.90 | 37,500 | 333,750 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 73 | 129 | 73 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 177 | 313 | 177 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 250 | 443 | 250 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 7.73 | 1,000 | 7,730 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,826 | 8,542 | 4,826 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,550 | 8,054 | 4,550 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 15,625 | 27,656 | 15,625 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 10.55 | 50,000 | 527,500 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 695 | 1,230 | 695 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 24,306 | 43,022 | 24,306 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 10.78 | 50,000 | 539,000 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 66 | 117 | 66 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 241 | 427 | 241 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 330 | 584 | 330 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 2,525 | 4,469 | 2,525 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 34.73 | 12,641 | 439,022 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 313 | 554 | 313 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 2,188 | 3,873 | 2,188 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 46.73 | 10,000 | 467,300 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 174 | 308 | 174 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 2,326 | 4,117 | 2,326 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 39.05 | 10,000 | 390,500 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 469 | 830 | 469 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 7,032 | 12,447 | 7,032 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 30.48 | 30,000 | 914,400 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 4,724 | 8,361 | 4,724 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 11,944 | 21,141 | 11,944 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 22.85 | 50,000 | 1,142,500 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | A | 1.77 | 16,667 | 29,501 | 16,667 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Kennedy Eugene P. | Chief Medical Offic ... | Option Exercise | D | 15.33 | 50,000 | 766,500 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | A | 1.77 | 18,506 | 32,756 | 18,506 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | A | 1.77 | 13,218 | 23,396 | 13,218 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Sherman Matthew L | Director | Option Exercise | D | 4.56 | 63,447 | 289,318 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 105 | 186 | 105 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 187 | 331 | 187 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 563 | 997 | 563 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 146 | 258 | 146 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 7.85 | 2,000 | 15,700 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 1,250 | 2,213 | 1,250 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 3,021 | 5,347 | 3,021 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 729 | 1,290 | 729 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 8.86 | 10,000 | 88,600 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 360 | 637 | 360 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 311 | 550 | 311 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 115 | 204 | 115 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 12.68 | 2,352 | 29,823 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 70 | 124 | 70 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 487 | 862 | 487 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 1,111 | 1,966 | 1,111 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 10.78 | 3,334 | 35,941 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 98 | 173 | 98 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 98 | 173 | 98 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 472 | 835 | 472 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 24.42 | 2,000 | 48,840 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 868 | 1,536 | 868 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | A | 1.77 | 1,633 | 2,890 | 1,633 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Lawley Lori D | Principal Accountin ... | Option Exercise | D | 52.64 | 10,000 | 526,400 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 4,437 | 7,853 | 4,437 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 17.42 | 13,309 | 231,843 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 2,392 | 4,234 | 2,392 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 10.78 | 4,783 | 51,561 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 8,887 | 15,730 | 8,887 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 10.78 | 17,773 | 191,593 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 1,588 | 2,811 | 1,588 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 44.60 | 6,349 | 283,165 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 5,220 | 9,239 | 5,220 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 21.23 | 15,659 | 332,441 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 4,000 | 7,080 | 4,000 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 14.71 | 12,000 | 176,520 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 3,571 | 6,321 | 3,571 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 13.30 | 10,713 | 142,483 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | A | 1.77 | 3,968 | 7,023 | 3,968 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Zoth Lota S. | Director | Option Exercise | D | 13.30 | 11,904 | 158,323 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 14,293 | 25,299 | 14,293 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 24,250 | 42,923 | 24,250 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 11,458 | 20,281 | 11,458 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 3.17 | 100,000 | 317,000 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,291 | 4,055 | 2,291 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,291 | 4,055 | 2,291 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,293 | 4,059 | 2,293 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 3,438 | 6,085 | 3,438 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 3,438 | 6,085 | 3,438 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 4,297 | 7,606 | 4,297 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 4,870 | 8,620 | 4,870 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 4,583 | 8,112 | 4,583 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 7.85 | 55,000 | 431,750 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 4,821 | 8,533 | 4,821 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,211 | 3,913 | 2,211 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 11,719 | 20,743 | 11,719 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 10.55 | 37,500 | 395,625 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 330 | 584 | 330 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 278 | 492 | 278 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 9,392 | 16,624 | 9,392 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 10.78 | 20,000 | 215,600 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 281 | 497 | 281 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 328 | 581 | 328 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 1,639 | 2,901 | 1,639 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 34.73 | 8,989 | 312,188 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 589 | 1,043 | 589 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 3,487 | 6,172 | 3,487 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 43.65 | 16,300 | 711,495 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,309 | 4,087 | 2,309 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 6,692 | 11,845 | 6,692 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 21.38 | 27,000 | 577,260 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 3,129 | 5,538 | 3,129 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 3,539 | 6,264 | 3,539 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 11.79 | 20,000 | 235,800 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,028 | 3,590 | 2,028 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 5,472 | 9,685 | 5,472 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 6.87 | 15,000 | 103,050 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 2,867 | 5,075 | 2,867 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 9,038 | 15,997 | 9,038 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 7.00 | 23,809 | 166,663 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 8,333 | 14,749 | 8,333 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 7.00 | 16,666 | 116,662 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | A | 1.77 | 1,190 | 2,106 | 1,190 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Langren Carl W. | Chief Financial Off ... | Option Exercise | D | 3.07 | 2,380 | 7,307 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 100,000 | 177,000 | 100,000 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 5,269 | 9,326 | 5,269 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 5,269 | 9,326 | 5,269 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 5,275 | 9,337 | 5,275 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 6,158 | 10,900 | 6,158 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 7,907 | 13,995 | 7,907 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 7,907 | 13,995 | 7,907 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 14,926 | 26,419 | 14,926 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 10,542 | 18,659 | 10,542 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 7.85 | 126,500 | 993,025 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 3,477 | 6,154 | 3,477 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 19,531 | 34,570 | 19,531 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 19,531 | 34,570 | 19,531 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 19,532 | 34,572 | 19,532 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 19,532 | 34,572 | 19,532 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 25,820 | 45,701 | 25,820 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 48,828 | 86,426 | 48,828 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 10.55 | 312,500 | 3,296,875 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 439 | 777 | 439 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 190 | 336 | 190 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 2,195 | 3,885 | 2,195 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 18,246 | 32,295 | 18,246 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 34.73 | 84,275 | 2,926,871 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 813 | 1,439 | 813 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 19,438 | 34,405 | 19,438 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 43.65 | 81,000 | 3,535,650 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 1,710 | 3,027 | 1,710 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 22,041 | 39,013 | 22,041 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 21.38 | 71,250 | 1,523,325 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 3,129 | 5,538 | 3,129 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 26,872 | 47,563 | 26,872 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 11.79 | 90,000 | 1,061,100 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 8,080 | 14,302 | 8,080 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 31,921 | 56,500 | 31,921 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 6.87 | 80,000 | 549,600 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 7,143 | 12,643 | 7,143 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 14,286 | 25,286 | 14,286 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 7.00 | 42,857 | 299,999 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 95,238 | 168,571 | 95,238 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 3.07 | 190,476 | 584,761 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 22,580 | 39,967 | 22,580 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | A | 1.77 | 167,896 | 297,176 | 167,896 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Vahanian Nicholas N. | President | Option Exercise | D | 2.97 | 380,952 | 1,131,427 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 13,889 | 24,584 | 13,889 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 5.33 | 27,777 | 148,051 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 4,437 | 7,853 | 4,437 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 17.42 | 13,309 | 231,843 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 2,391 | 4,232 | 2,391 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 10.78 | 4,782 | 51,550 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 8,887 | 15,730 | 8,887 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 10.78 | 17,774 | 191,604 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 1,588 | 2,811 | 1,588 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 44.60 | 6,349 | 283,165 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 5,220 | 9,239 | 5,220 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 21.23 | 15,659 | 332,441 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 4,000 | 7,080 | 4,000 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 14.71 | 12,000 | 176,520 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 5,952 | 10,535 | 5,952 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 13.30 | 17,855 | 237,472 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 23,810 | 42,144 | 23,810 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 7.00 | 47,619 | 333,333 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 1,786 | 3,161 | 1,786 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 7.00 | 3,571 | 24,997 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 8,929 | 15,804 | 8,929 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 10.02 | 17,857 | 178,927 | 0 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | A | 1.77 | 13,095 | 23,178 | 13,095 | |
| Aug 02 2019 | NLNK | NEWLINK GENETICS C ... | Raffin Thomas A. | Director | Option Exercise | D | 3.07 | 26,190 | 80,403 | 0 |